BlossomHill Therapeutics, Inc. Common Stock Financial Flexibility Index
BlossomHill Therapeutics, Inc. Common Stock financial flexibility index. BlossomHill Therapeutics, Inc. Common Stock (BLSM) has a Financial Flexibility Index of -0.07x as of March 2026. Free cash flow of $-20.93 Million (operating CF $-20.94 Million minus capex $13.00K) represents 0% of total liabilities ($295.53 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of BlossomHill Therapeutics, Inc. Common Stock (2024–2025)
Financial flexibility index of BlossomHill Therapeutics, Inc. Common Stock from 2024 to 2025. Historical Financial Flexibility Index trend for BlossomHill Therapeutics, Inc. Common Stock across 2 annual periods. Explore BlossomHill Therapeutics, Inc. Common St (BLSM) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
BlossomHill Therapeutics, Inc. Common Stock Financial Flexibility Index by Year (2024–2025)
BlossomHill Therapeutics, Inc. Common Stock financial flexibility index by year from 2024 to 2025. Year-by-year free cash flow to debt coverage for BlossomHill Therapeutics, Inc. Common Stock. For the full cash flow conversion analysis, see BlossomHill Therapeutics, Inc. Common St cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.16x | $-45.86 Million | $-46.92 Million | $294.70 Million | ▲ +10.7% |
| 2024 | -0.17x | $-31.32 Million | $-31.42 Million | $179.66 Million | — |